The neurodevelopmental disorders to be covered by the centre will include neuromotor impairments, motor delay, language delay, cognitive delay, and epilepsy. Along with these, vision and hearing impairments will be covered as co-morbidities.
Deputy Director Administration AIIMS V Srinivas said that the institute has received the Health Ministry's approval for establishing the Rs 14.3 crore centre.
The proposal for establishing the centre for excellence was conceptualised by a team of Senior Faculty led by Prof VK Paul and Prof Sheffali Gulati.
"The state-of-the-art centre will provide high quality affordable care for all sections of the society, perform high end diagnostic and therapeutic research and act as an education and training hub," Srinivas said.
"The five key elements of the centre of excellence are creation of a National Registry, the National Knowledge and Training Centre, Advanced Diagnostics, Advanced Therapeutics & Rehabilitation and a Helpline for Teleconsultation.
"The National Registry will be the first of its kind in the country paving the way for meaningful research, policy making and advocacy for childhood neurodevelopment disorders in India," he said.
The genetic tests would help in antenatal counselling preventing further birth of affected children in families and unveiling of newer pathogenic and therapeutic pathways.
"The centre of excellence will focus on use of technology aided rehabilitation strategies for children with neurodevelopmental disorders. This will be done in collaboration with IIT Delhi utilising textile technology and biomedical engineering," Srinivas said.
The Centre will come up at the Mother and Child Block of AIIMS.
The Centre of Excellence will provide reliable, round-the-clock, toll free telephonic guidance. It is expected that the quality of life of both health care providers and patients and their families would improve significantly with these measures.
The IIFCL is also considering funding an AIIMS Endowment Chair for Childhood Neurodevelopmental Disorders amounting to Rs. 8 lakhs per annum for organizing conclaves, capacity building in research and formulation of treatment guidelines and advocacy policies, he said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
